Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences

Abstract The design of superior biologic therapeutics, including antibodies and engineered proteins, involves optimizing their specific ability to bind to disease-related molecular targets. Previously, we developed and applied the Assisted Design of Antibody and Protein Therapeutics (ADAPT) platform...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christopher R. Corbeil, Mahder Seifu Manenda, Traian Sulea, Jason Baardsnes, Marie-Ève Picard, Hervé Hogues, Francis Gaudreault, Christophe Deprez, Rong Shi, Enrico O. Purisima
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/32593c24308a497ea7ce2a68ef263f47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32593c24308a497ea7ce2a68ef263f47
record_format dspace
spelling oai:doaj.org-article:32593c24308a497ea7ce2a68ef263f472021-11-08T10:52:07ZRedesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences10.1038/s41598-021-00669-w2045-2322https://doaj.org/article/32593c24308a497ea7ce2a68ef263f472021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-00669-whttps://doaj.org/toc/2045-2322Abstract The design of superior biologic therapeutics, including antibodies and engineered proteins, involves optimizing their specific ability to bind to disease-related molecular targets. Previously, we developed and applied the Assisted Design of Antibody and Protein Therapeutics (ADAPT) platform for virtual affinity maturation of antibodies (Vivcharuk et al. in PLoS One 12(7):e0181490, https://doi.org/10.1371/journal.pone.0181490 , 2017). However, ADAPT is limited to point mutations of hot-spot residues in existing CDR loops. In this study, we explore the possibility of wholesale replacement of the entire H3 loop with no restriction to maintain the parental loop length. This complements other currently published studies that sample replacements for the CDR loops L1, L2, L3, H1 and H2. Given the immense sequence space theoretically available to H3, we focused on the virtual grafting of over 5000 human germline-derived H3 sequences from the IGMT/LIGM database increasing the diversity of the sequence space when compared to using crystalized H3 loop sequences. H3 loop conformations are generated and scored to identify optimized H3 sequences. Experimental testing of high-ranking H3 sequences grafted into the framework of the bH1 antibody against human VEGF-A led to the discovery of multiple hits, some of which had similar or better affinities relative to the parental antibody. In over 75% of the tested designs, the re-designed H3 loop contributed favorably to overall binding affinity. The hits also demonstrated good developability attributes such as high thermal stability and no aggregation. Crystal structures of select re-designed H3 variants were solved and indicated that although some deviations from predicted structures were seen in the more solvent accessible regions of the H3 loop, they did not significantly affect predicted affinity scores.Christopher R. CorbeilMahder Seifu ManendaTraian SuleaJason BaardsnesMarie-Ève PicardHervé HoguesFrancis GaudreaultChristophe DeprezRong ShiEnrico O. PurisimaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Christopher R. Corbeil
Mahder Seifu Manenda
Traian Sulea
Jason Baardsnes
Marie-Ève Picard
Hervé Hogues
Francis Gaudreault
Christophe Deprez
Rong Shi
Enrico O. Purisima
Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
description Abstract The design of superior biologic therapeutics, including antibodies and engineered proteins, involves optimizing their specific ability to bind to disease-related molecular targets. Previously, we developed and applied the Assisted Design of Antibody and Protein Therapeutics (ADAPT) platform for virtual affinity maturation of antibodies (Vivcharuk et al. in PLoS One 12(7):e0181490, https://doi.org/10.1371/journal.pone.0181490 , 2017). However, ADAPT is limited to point mutations of hot-spot residues in existing CDR loops. In this study, we explore the possibility of wholesale replacement of the entire H3 loop with no restriction to maintain the parental loop length. This complements other currently published studies that sample replacements for the CDR loops L1, L2, L3, H1 and H2. Given the immense sequence space theoretically available to H3, we focused on the virtual grafting of over 5000 human germline-derived H3 sequences from the IGMT/LIGM database increasing the diversity of the sequence space when compared to using crystalized H3 loop sequences. H3 loop conformations are generated and scored to identify optimized H3 sequences. Experimental testing of high-ranking H3 sequences grafted into the framework of the bH1 antibody against human VEGF-A led to the discovery of multiple hits, some of which had similar or better affinities relative to the parental antibody. In over 75% of the tested designs, the re-designed H3 loop contributed favorably to overall binding affinity. The hits also demonstrated good developability attributes such as high thermal stability and no aggregation. Crystal structures of select re-designed H3 variants were solved and indicated that although some deviations from predicted structures were seen in the more solvent accessible regions of the H3 loop, they did not significantly affect predicted affinity scores.
format article
author Christopher R. Corbeil
Mahder Seifu Manenda
Traian Sulea
Jason Baardsnes
Marie-Ève Picard
Hervé Hogues
Francis Gaudreault
Christophe Deprez
Rong Shi
Enrico O. Purisima
author_facet Christopher R. Corbeil
Mahder Seifu Manenda
Traian Sulea
Jason Baardsnes
Marie-Ève Picard
Hervé Hogues
Francis Gaudreault
Christophe Deprez
Rong Shi
Enrico O. Purisima
author_sort Christopher R. Corbeil
title Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
title_short Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
title_full Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
title_fullStr Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
title_full_unstemmed Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
title_sort redesigning an antibody h3 loop by virtual screening of a small library of human germline-derived sequences
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/32593c24308a497ea7ce2a68ef263f47
work_keys_str_mv AT christopherrcorbeil redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT mahderseifumanenda redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT traiansulea redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT jasonbaardsnes redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT marieevepicard redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT hervehogues redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT francisgaudreault redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT christophedeprez redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT rongshi redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
AT enricoopurisima redesigninganantibodyh3loopbyvirtualscreeningofasmalllibraryofhumangermlinederivedsequences
_version_ 1718442510110425088